<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>PBPK on Vegan Scientist</title><link>https://veganscientist.org/en/tags/pbpk/</link><description>Recent content in PBPK on Vegan Scientist</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Tue, 17 Nov 2026 09:00:00 +0100</lastBuildDate><atom:link href="https://veganscientist.org/en/tags/pbpk/index.xml" rel="self" type="application/rss+xml"/><item><title>Computational modeling: a new step toward reducing animal testing</title><link>https://veganscientist.org/en/blog/modellazione-computazionale-nuovo-metodo-ridurre-sperimentazione-animale/</link><pubDate>Tue, 17 Nov 2026 09:00:00 +0100</pubDate><guid>https://veganscientist.org/en/blog/modellazione-computazionale-nuovo-metodo-ridurre-sperimentazione-animale/</guid><description>&lt;p&gt;&lt;strong&gt;Science and animal rights can move in the same direction.&lt;/strong&gt;&lt;/p&gt;&#10;&lt;p&gt;On April 10, 2025, the Food and Drug Administration (FDA), the U.S. agency that regulates drugs and other health products, announced a plan to reduce, refine, and, where possible, replace certain animal tests in drug development. The starting point is &lt;strong&gt;monoclonal antibodies&lt;/strong&gt;, with the aim of gradually extending the approach to other categories of medicines.&lt;/p&gt;&#10;&lt;p&gt;This is not a blanket ban on animal testing, nor has the replacement of animal studies already been achieved. But it is a substantial step: a stated commitment to evaluating drug safety using data and models that are more directly relevant to humans.&lt;/p&gt;</description></item></channel></rss>